by ComplianceQuest

My Dashboard Inspection Tracker FDA Guidance Templates Assessments

Sign in Get started

Tracker Overview Enforcement Themes Form 483s Warning Letters Inspections Recalls Investigators Companies Facilities

ANALYTICS

Tracker Overview Enforcement Themes

FDA ACTIONS

Form 483s Warning Letters Inspections Recalls

AUDIT READINESS

COMPANIES

Companies Facilities

Loading…

Dashboard Warning LettersWarning Letter Details

American Pharma Mfg. Inc. Warning Letter Details

Warning Letter

American Pharma Mfg. Inc.

1845 S. Vineyard Ave Ste 5 Ontario , CA 91761-7762 United States

Issue DateAugust 04, 2026

FEI NumberN/A

Violations5

CountryUnited States

Issuing Office

Human Foods Program

Product Type

Dietary Supplements

Status

Open

Subject

CGMP/Dietary Supplement/Adulterated/Misbranded

American Pharma Mfg. Inc. FDA Warning Letter, August 4, 2026